Iconix Provides Chemogenomic Profiling Services to AstraZeneca

Jun 02, 2004

NEW YORK, June 2 (GenomeWeb News) - Iconix Pharmaceuticals will provide chemogenomic profiling services for AstraZeneca, the company said today.

Under the agreement, Mountain View, Calif.-based Iconix will profile compounds from AstraZeneca for toxicity using its Drug Signatures library, a collection of predictive biomarkers derived from its chemogenomics reference database.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Breaking News

The Scan

From Relatives to Suspects

Parabon NanoLabs is partnering with law enforcement to use genetic genealogy approaches to solve cold cases, Buzzfeed News reports.

Family Ties

A Columbia University-led team used emergency contact information from medical records to create family trees and estimate disease heritability.

Time to Kick Back With Some Golf

NPR says a new report recommends that former research chimpanzees should be moved to retirement sanctuaries unless that move would shorten their lives.

This Week in Science

In Science this week: ancient Southeast Asian genomes provide insight on human migration, and more.

Main menu